- Keybanc cut the price target for LyondellBasell Industries N.V. LYB from $85 to $74. Keybanc analyst Aleksey Yefremov maintained an Underweight rating. LyondellBasell shares fell 3.7% to close at $84.16 on Wednesday.
- HC Wainwright & Co. boosted the price target for Aravive, Inc. ARAV from $7 to $12. HC Wainwright & Co. analyst Joseph Pantginis maintained a Buy rating. Aravive shares fell 4.2% to close at $1.61 on Wednesday.
- DA Davidson raised the price target for e.l.f. Beauty, Inc. ELF from $77 to $91. DA Davidson analyst Linda Bolton Weiser maintained a Buy rating. e.l.f. Beauty shares rose 1.8% to close at $73.33 on Wednesday.
- Stifel raised FedEx Corporation FDX price target from $171 to $222. Stifel analyst J. Bruce Chan upgraded the stock from Hold to Buy. FedEx shares rose 2.1% to $199.35 in pre-market trading.
- Telsey Advisory Group cut BRC Inc. BRCC price target from $12 to $10. Telsey Advisory Group analyst Sarang Vora maintained an Outperform rating. BRC shares rose 2.8% to close at $6.17 on Wednesday.
- Citigroup boosted the price target for Netflix, Inc. NFLX from $395 to $400. Citigroup analyst Jason Bazinet maintained a Buy rating on the stock. Netflix shares rose 3% to close at $303.79 on Wednesday.
- JP Morgan boosted Adobe Inc. ADBE price target from $365 to $380. JP Morgan analyst Mark Murphy maintained a Neutral rating. Adobe shares rose 6.1% to $353.82 in pre-market trading.
- Jefferies raised Sportradar Group AG SRAD price target from $10 to $11. Jefferies analyst David Katz maintained a Hold rating. Sportradar shares fell 10.7% to close at $10.50 on Wednesday.
- Wells Fargo raised The Progressive Corporation PGR price target from $116 to $158. Wells Fargo analyst Elyse Greenspan upgraded the stock from Underweight to Overweight. Progressive shares rose 0.6% to $135.87 in pre-market trading.
- Chardan Capital cut Freightos Limited CRGO price target from $13 to $11. Chardan Capital analyst Brian Dobson maintained a Buy rating. Freightos shares fell 1.2% to close at $3.99 on Wednesday.
- Needham cut Esperion Therapeutics, Inc. ESPR price target $16 to $12. Needham analyst Serge Belanger maintained a Buy rating. Esperion Therapeutics shares fell 53% to $1.87 in pre-market trading.
Check This Out: Insiders Selling Micron, KeyCorp And 2 Other Stocks
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Posted In: NewsPenny StocksPrice TargetSmall CapPre-Market OutlookMarketsAnalyst RatingsTrading Ideasanalyst forecastsPT Changes
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in